ANIK FY 2021 Earnings — Anika Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ANIKAnika Therapeutics, Inc.

$213M

FY 2021 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$148M+13.3% YoY

Gross Profit

$83M56.1% margin

Operating Income

$3M1.8% margin

Net Income

$4M2.8% margin

EPS (Diluted)

$0.28

Cash Flow

Operating Cash Flow

$8M

Free Cash Flow

$3M

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$348M

Total Liabilities

$60M

Stockholders' Equity

$287M

Cash & Equivalents

$94M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$148M	$130M	+13.3%
Gross Profit	$83M	$69M	+20.2%
Operating Income	$3M	-$28M	+109.2%
Net Income	$4M	-$24M	+117.2%